The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.
Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen
Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.
Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.